Millennium Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Millennium Management’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$404K	Sell	131,522 -61,619	-32%	-$189K	﹤0.01%	4871
2025 Q4	$688K	Sell	193,141 -757,860	-80%	-$2.81M	﹤0.01%	4741
2025 Q3	$3.32M	Buy	951,001 +545,992	+135%	+$1.87M	﹤0.01%	3546
2025 Q2	$830K	Buy	+405,009	New	+$1.01M	﹤0.01%	4550
2024 Q3	–	Sell	-109,207	Closed	-$50.2K	–	6483
2024 Q2	$50.2K	Sell	109,207 -39,057	-26%	-$33.3K	﹤0.01%	5415
2024 Q1	$234K	Sell	148,264 -27,148	-15%	-$51.6K	﹤0.01%	5289
2023 Q4	$358K	Buy	175,412 +78,090	+80%	+$135K	﹤0.01%	4852
2023 Q3	$136K	Sell	97,322 -105,356	-52%	-$109K	﹤0.01%	5252
2023 Q2	$112K	Buy	+202,678	New	+$107K	﹤0.01%	5302
2022 Q3	–	Sell	-121,145	Closed	-$613K	–	7499
2022 Q2	$613K	Sell	121,145 -38,678	-24%	-$282K	﹤0.01%	4791
2022 Q1	$1.14M	Buy	+159,823	New	+$1.08M	﹤0.01%	4405
2021 Q4	–	Sell	-1,582,630	Closed	-$15.7M	–	7382
2021 Q3	$15.7M	Buy	1,582,630 +83,190	+6%	+$826K	0.01%	1555
2021 Q2	$14.9M	Buy	1,499,440 +7,415	+0.5%	+$74.6K	0.01%	1483
2021 Q1	$14.9M	Sell	1,492,025 -84,575	-5%	-$901K	0.01%	1365
2020 Q4	$17M	Hold	1,576,600	–	–	0.01%	1206
2020 Q3	$16.4K	Buy	1,576,600 +1,466,800	+1,336%	+$15.2M	0.02%	909
2020 Q2	$1.1M	Buy	+109,800	New	+$1.09M	﹤0.01%	2933

Other funds holding STLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

KWM

Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management's STLN Position: Q1 2026 in Review

Millennium Management reduced its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 32% in Q1 2026, selling an estimated $189K and leaving 131,522 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #4871.

Millennium Management first reported a position in STLN in Q2 2020 and has held it in 17 quarters since. The position peaked at $17M in Q4 2020. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

Millennium Management held 131,522 shares of Starling Oncology Institute, Inc. Common Stock worth $404K as of Q1 2026.
Millennium Management sold 61,619 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $189K.
Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4871 holding.
Millennium Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2020 and has held it in 17 quarters since.
Millennium Management's Starling Oncology Institute, Inc. Common Stock position peaked at $17M in Q4 2020.
115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.